Evidence-based guideline: premature ovarian insufficiency†‡
ASRM C, Panay N, Anderson R, Bennie A, Cedars M, Davies M, Ee C, Gravholt C, Kalantaridou S, Kallen A, Kim K, Misrahi M, Mousa A, Nappi R, Rocca W, Ruan X, Teede H, Vermeulen N, Vogt E, Vincent A. Evidence-based guideline: premature ovarian insufficiency†‡. Climacteric 2024, 27: 510-520. PMID: 39647506, DOI: 10.1080/13697137.2024.2423213.Peer-Reviewed Original ResearchConceptsProvision of careGuideline development groupAnti-Mullerian hormoneFollicle stimulating hormoneHealthcare professionalsHormone therapyScoping surveyClinical questionsSurvey of womenElevated follicle stimulating hormoneFollicle stimulating hormone measurementsEuropean Society of Human Reproduction and Embryology (ESHREDevelopment groupQuality of lifeRandomized Controlled TrialsCombined oral contraceptivesPractice careGeneral well-beingAnti-Mullerian hormone testCognitive healthIntegrative reviewNon-hormonal treatmentsESHRE Executive CommitteeWomen's healthMuscle healthO-111 Premature ovarian insufficiency: new data and updated guidance
Panay N, Anderson R, Bennie A, Cedars M, Davies M, Ee C, Gravholt C, Kalantaridou S, Kallen A, Kim K, Misrahi M, Nappi R, Rocca W, Ruan X, Teede H, Vermeulen N, Vogt E, Vincent A. O-111 Premature ovarian insufficiency: new data and updated guidance. Human Reproduction 2024, 39: deae108.122. DOI: 10.1093/humrep/deae108.122.Peer-Reviewed Original ResearchPremature ovarian insufficiencyAmerican Society for Reproductive MedicineEvidence-based recommendationsOvarian insufficiencyInternational Menopause SocietyDiagnosis of premature ovarian insufficiencyIatrogenic premature ovarian insufficiencyManagement of premature ovarian insufficiencyClinical questionsNon-hormonal treatmentsHormone therapyFertility preservationTreatment optionsClinical managementMenopause SocietyGuideline groupDevastating conditionEuropean guidelinesHormone treatmentClinical guidanceSexual functionReproductive medicineMusculoskeletal healthMuscle healthWomen's healthManaging menopause after cancer
Hickey M, Basu P, Sassarini J, Stegmann M, Weiderpass E, Nakawala Chilowa K, Yip C, Partridge A, Brennan D. Managing menopause after cancer. The Lancet 2024, 403: 984-996. PMID: 38458217, DOI: 10.1016/s0140-6736(23)02802-7.Peer-Reviewed Original ResearchConceptsPremature ovarian insufficiencyMenopausal symptomsRisk of chronic conditionsLong-term effects of cancer treatmentHormone therapyOvarian insufficiencyPatient-focused modelModels of careVasomotor symptomsBreast cancerEffects of cancer treatmentCancer treatmentSexual dysfunctionHigh-income countriesMenopausal hormone therapyQuality of lifeTreatment-induced symptomsLow-income countriesNon-hormonal treatmentsNon-hormonal optionsChronic conditionsManaging menopausal symptomsManaging menopauseDiagnose menopauseVaginal estrogen
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply